| scholarly article | Q13442814 |
| P2093 | author name string | X. Wang | |
| Y. L. Hurd | |||
| E. Keller | |||
| D. Dow-Edwards | |||
| P2860 | cites work | Developmental expression of G proteins that differentially modulate adenylyl cyclase activity in mouse brain | Q44665898 |
| Preprotachykinin-A mRNA expression in the human and monkey brain: An in situ hybridization study | Q48164642 | ||
| Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats | Q48389730 | ||
| Distribution of cannabinoid receptor messenger RNA in the human brain: an in situ hybridization histochemistry with oligonucleotides | Q48443541 | ||
| Ontogeny of the striatal neurons expressing the D2 dopamine receptor in humans: an in situ hybridization and receptor-binding study. | Q48617697 | ||
| Atypical location of cannabinoid receptors in white matter areas during rat brain development | Q48679760 | ||
| Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study. | Q52144462 | ||
| Ontogeny of the striatal neurons expressing the D1 dopamine receptor in humans. | Q52201039 | ||
| Ontogeny of the striatal neurons expressing neuropeptide genes in the human fetus and neonate. | Q52205943 | ||
| Effects of prenatal marijuana exposure on child behavior problems at age 10 | Q73855145 | ||
| Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat | Q74184497 | ||
| The effects of cannabinoids on the brain | Q28137626 | ||
| Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
| Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 | ||
| Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 | ||
| A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function | Q34198827 | ||
| Pharmacology of cannabinoid CB1 and CB2 receptors. | Q34442847 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| Endogenous cannabinoid ligands--chemical and biological studies | Q36831123 | ||
| Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry | Q38331458 | ||
| Cannabinoid pharmacology | Q39741984 | ||
| Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons | Q42450378 | ||
| Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain | Q42451047 | ||
| Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period | Q42475353 | ||
| Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains | Q42490661 | ||
| Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement | Q42504533 | ||
| Localization of cannabinoid receptor mRNA in rat brain | Q42510202 | ||
| Autoradiographic study of pre- and postnatal distribution of cannabinoid receptors in human brain | Q43798328 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoid receptor | Q421237 |
| cannabinoids | Q422936 | ||
| CNR2 | Q17907844 | ||
| P1104 | number of pages | 14 | |
| P304 | page(s) | 681-694 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Neuroscience | Q15708571 |
| P1476 | title | Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain | |
| P478 | volume | 118 |
| Q34098209 | Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models |
| Q37444802 | Basic neuroanatomy and neuropharmacology of cannabinoids |
| Q37629266 | Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications |
| Q35950914 | Cannabinoids and gene expression during brain development. |
| Q36511000 | Cannabis and neurodevelopment: implications for psychiatric disorders. |
| Q89746342 | Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review |
| Q37160448 | Cannabis, cannabinoids and schizophrenia: integration of the evidence |
| Q47113406 | Chronic exposure to cannabinoids during adolescence causes long-lasting behavioral deficits in adult mice |
| Q90660691 | Consequences of Perinatal Cannabis Exposure |
| Q61449907 | Contribution of Altered Endocannabinoid System to Overactive mTORC1 Signaling in Focal Cortical Dysplasia |
| Q64102147 | Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions |
| Q36090358 | Cortical thinness and volume differences associated with marijuana abuse in emerging adults |
| Q30395013 | Developmental consequences of fetal exposure to drugs: what we know and what we still must learn |
| Q37553166 | Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations. |
| Q34519223 | Developmental increase in hippocampal endocannabinoid mobilization: role of metabotropic glutamate receptor subtype 5 and phospholipase C. |
| Q30505485 | Developmental regulation of CB1-mediated spike-time dependent depression at immature mossy fiber-CA3 synapses |
| Q34350080 | Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex |
| Q44351862 | Discrete opioid gene expression impairment in the human fetal brain associated with maternal marijuana use. |
| Q24650912 | Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning |
| Q30373359 | Endocannabinoid signalling in reward and addiction. |
| Q34245130 | Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor |
| Q36348362 | Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development |
| Q59791745 | Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression |
| Q38784874 | High times for cannabis: Epigenetic imprint and its legacy on brain and behavior |
| Q92305982 | Interaction of maternal choline levels and prenatal Marijuana's effects on the offspring |
| Q34521105 | Keep off the grass? Cannabis, cognition and addiction |
| Q35655078 | Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. |
| Q37136294 | Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions |
| Q27009287 | Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization |
| Q24633636 | Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment |
| Q37143586 | Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development |
| Q34990029 | Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome |
| Q48474808 | Neuroimaging of prenatal drug exposure. |
| Q35694094 | Neuronal substrates and functional consequences of prenatal cannabis exposure |
| Q26752739 | Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants |
| Q92097819 | Physiology of the Endocannabinoid System During Development |
| Q36612284 | Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. |
| Q39556033 | Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis |
| Q33932087 | Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia |
| Q34268010 | Requirement of cannabinoid CB1 receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections |
| Q38682524 | Role of the endocannabinoid system in vertebrates: Emphasis on the zebrafish model |
| Q36001354 | Sex-specific alterations in hippocampal cannabinoid 1 receptor expression following adolescent delta-9-tetrahydrocannabinol treatment in the rat. |
| Q39383802 | Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history |
| Q46919279 | Short- and long-term consequences of prenatal exposure to cannabis |
| Q50326139 | The Endocannabinoid System across Postnatal Development in Transmembrane Domain Neuregulin 1 Mutant Mice |
| Q37545714 | The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders. |
| Q37568621 | The endocannabinoid system during development: emphasis on perinatal events and delayed effects. |
| Q37892742 | The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives. |
| Q43075979 | The genetic epidemiology of substance use disorder: A review |
| Q36150541 | The safety of cannabinoids for the treatment of multiple sclerosis |
| Q37381132 | Trajectory of adolescent cannabis use on addiction vulnerability |
| Q38024934 | Type-1 cannabinoid receptor signaling in neuronal development |
Search more.